[Form 4] Healthpeak Properties, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Healthpeak Properties (DOC) Form 4: President & CEO Scott M. Brinker purchased 1,490 common shares on 08/04/2025 at $16.83, an outlay of roughly $25k. Post-transaction direct ownership rises to 211,906 shares. No derivative trades were reported. The filing reflects routine insider buying and does not alter control status; Brinker remains both a director and executive officer.

Positive

• Insider confidence: CEO purchased shares on the open market, signalling a personal bullish view.
• Ownership increase: Post-transaction stake rises to 211,906 shares, aligning management further with shareholders.

Negative

• Immaterial size: Only 1,490 shares (~$25k) limits the transaction’s significance.
• No strategic information: Filing lacks guidance or operational updates, offering little insight into fundamentals.

Insights

Equity Analyst

TL;DR: Small CEO buy is mildly bullish but not thesis-changing.

The P-code purchase, though positive for sentiment, represents under 1% of Brinker's existing stake and an immaterial cash amount for a $16 bn+ REIT. Insider buying after the recent pullback suggests confidence in valuation and upcoming fundamentals, yet the scale limits predictive power for earnings or NAV trajectory. Investors may view it as an incremental vote of confidence rather than a catalyst.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Brinker Scott M

(Last) (First) (Middle)

4600 SOUTH SYRACUSE STREET

SUITE 500

(Street)

DENVER CO 80237

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
HEALTHPEAK PROPERTIES, INC. [ DOC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President and CEO

3. Date of Earliest Transaction (Month/Day/Year)
08/04/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/04/2025		P		1,490	A	$16.83	211,906	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

	Carol Samaan, SVP, Legal (Attorney-In-Fact)	08/04/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many Healthpeak (DOC) shares did the CEO buy?

Scott M. Brinker bought 1,490 common shares.

What was the purchase price disclosed in the Form 4?

The shares were acquired at $16.83 each.

What is the CEO's total direct ownership after the transaction?

Brinker now directly owns 211,906 DOC shares.

Was this an open-market purchase or an option exercise?

The transaction code "P" indicates an open-market purchase.

Did the Form 4 report any derivative security activity?

No derivative securities were acquired or disposed of in this filing.